BASF Enzymes and Lallemand Biofuels & Distilled Spirits (LBDS) have formally entered into a marketing and sales collaboration agreement with the aim to ‘maximise value to customers in the ethanol market in the United States.’ In the collaboration, BASF’s enzyme portfolio will be used for applications in liquefaction and fermentation to improve fermentation performance. LBDS will use its TransFerm yeast product line which it claims provides increased ethanol yields and reduces the need for glucoamylase addition. “Collaborating with LBDS is a key milestone in our efforts to better serve our customers with increased-value to their bottom line,” said Dirk Daems, BASF director of Operations, in a statement. With more than 115,000 employees worldwide, BASF states its objective is to ‘create chemistry for a sustainable future.’ The company’s portfolio is organised into five segments, chemicals, performance products, functional materials & solutions, agricultural solutions and oil & gas. LBDS is based in Duluth, Georgia. It is a supplier of fermentation ingredients and ‘value creating services’ to the global fuel ethanol and distilled beverage industries.
BASF Enzymes and Lallemand Biofuels & Distilled Spirits (LBDS) have entered a marketing and sales agreement for the US ethanol market in which BASF's enzyme portfolio will be used to improve fermentation, while LBDS will use its TransFerm yeast product line, which enables increased ethanol yields and reduces the need for glucoamylase. The partnership will add value to customers' bottom lines, said Dirk Daems, director of operations, BASF. LBDS supplies fermentation ingredients to the ethanol market and distilled beverage industry.